$BSX BOSTON SCIENTIFIC HAS TROUBLE AHEAD.
Yesterdays enforcement by the FDA for BSX to remove one of its products from the market is a significant blow to BSX and has sent investors running scared. Fears from legal actions by clients are a definite and real possibility which will send the price into further correction in out opinion.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。